Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AB, absolute, accommodate, acetaminophen, aimed, algorithm, Annex, Arbitrage, Asia, attend, augment, begun, Beijing, benign, breach, campaign, cardiovascular, categorization, certified, cessation, China, clarify, clock, commonly, configured, consortium, convene, correspondingly, counsel, count, coupled, CPA, cycle, defamed, denying, description, Designee, diameter, diminish, distributor, duty, education, educational, Elizabeth, endeavor, entail, exploring, fiduciary, fill, forecasted, Gen, Goldberg, graphical, Grid, hand, head, Hong, honoring, hypoglycemic, interference, introductory, Kong, launch, leveraged, lower, lowest, Macau, manual, MARD, marketplace, membership, Michael, minute, moderate, MTIA, mutual, NE, nominate, nominated, Nominating, numerical, oncology, panel, pilot, Pin, pivotal, poster, predicate, prejudice, prelaunch, put, quickly, recapitalization, recovering, referenced, registry, reorganization, Republic, restructuring, retroactively, Room, session, Shang, Sino, solicit, Specimen, split, stringent, SUD, surgery, surgical, symposia, Taiwan, target, targeted, Tau, Tech, theory, Tradeshow, TUV, uncover, undergone, unspecified, usability, usage, user, vacancy, verified, waiting, Washington, wife, workforce
Removed:
absorption, accept, acute, ADA, adding, administer, administered, afraid, agent, amenable, analyte, assembly, attempt, attributed, Aurora, bid, billion, biotechnology, Boenning, build, Burnham, cancer, carbohydrate, challenging, chemical, chemistry, chronic, comfort, commit, concentrated, content, cure, curing, dedicated, detailed, diagnosed, diet, dilutive, discovery, disease, division, dosage, doubtful, drastic, element, expanded, exposing, extending, extreme, fat, fifty, fluidity, goal, grow, guide, Hill, hormone, hypoglycemia, identity, IND, infrastructure, injectable, insufficiently, invasive, LifeTech, lipid, Monarch, national, NDA, nonirritating, nontoxic, nutrition, objective, OTC, OTCBB, outmost, overlap, owe, parenteral, permeability, pipeline, pocket, pool, population, positioned, preclude, preliminary, preserve, prevented, productivity, Project, properly, purity, qualifying, ranging, refuse, repaid, requesting, resistance, restrict, retail, round, Scattergood, sequential, serving, sharply, Sherbrooke, specific, strength, synergistic, systemic, systemically, tightening, tightly, tolerance, tooling, topically, treat, type, uncollectible, undelivered, unmet, unrelated, unwanted, utilizing, vested, viable
Filing tables
Filing exhibits
- 10-K Annual report
- 3.6 Certificate of Designation, Preferences and Rights of Series E Convertible Preferred Stock Dated December 10, 2013.
- 4.8 Form of Warrant to Purchase Common Stock Dated December 10, 2013.
- 10.31 License Development and Commercialization Agreement by and Between the Company and Medical Technologies Innovations Asia, LTD, Dated December 9, 2013
- 10.32 Securities Purchase Agreement by and Between the Company and Medical Technologies Innovations Asia, LTD and Beijing Sino Tau Shang Pin Tech and Development Corp., Dated December 10, 2013
- 10.33 Securities and Purchase Agreement by and Between the Company and Platinum Partners Value Arbitrage Fund L.P. and Platinum Partners Liquid Opportunity Master Fund L.P., Dated December 10, 2013
- 10.34 Second Amendment to the Consulting Agreement by and Between the Company and Robert F. Doman., Dated December 26, 2013
- 10.35 First Amendment to the Securities Purchase Agreement and License, Development and Commercialization Agreement by and Between the Company and Medical Technologies Innovations Asia, LTD and Beijing Sino Tau Shang Pin Tech, Dated January 30, 2014
- 21.1 Subsidiaries of the Company.
- 23.1 Consent of Wolf & Company, P.C., Independent Registered Public Accounting Firm.
- 31.1 Certification of Chief Executive Officer Pursuant to Rule 13A-14 (A) Under the Securities Exchange Act of 1934, As Amended, As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002.
- 31.2 Certification of Chief Financial Officer Pursuant to Rule 13A-14 (A) Under the Securities Exchange Act of 1934, As Amended, As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002.
- 32.1 Certification of Chief Executive Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- 32.2 Certification of Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- Download Excel data file
- View Excel data file
ECTE similar filings
Filing view
External links
Exhibit 10.34
SECOND AMENDMENT
TO CONSULTING AGREEMENT
This SECOND AMENDMENT TO CONSULTING AGREEMENT is entered into as of December 26, 2013 (the “Amendment”) by and between Echo Therapeutics, Inc., a Delaware corporation (the “Company”), and Robert F. Doman, an individual (“Consultant”).
RECITALS
WHEREAS, reference is hereby made to the Consulting Agreement entered into as of August 26, 2013 (as amended, restated, supplemented or otherwise modified, the “Agreement”) by and between Consultant and the Company; and
WHEREAS, Consultant and the Company have mutually agreed that the term of the Agreement be amended as set forth herein.
NOW, THEREFORE, the parties hereto agree as follows:
1. Defined Terms. Unless otherwise defined herein, terms used herein are used as defined in the Agreement, as amended hereby.
2. Amendment of the Agreement. Section 2 of the Agreement is hereby amended by deleting the phrase “for a period of four months” and replacing it with “until March 26, 2014”. Except as expressly modified herein, all other provisions of the Agreement shall remain unchanged and in full force and effect.
3. Effective Date. This Amendment shall be effective as of December 26, 2013.
4. Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania.
-1-
IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to Consulting Agreement to be duly executed as of the date first above written.
ECHO THERAPEUTICS, INC. |
By: /s/ William Grieco |
William Grieco
Chairman, Nominating and Corporate
Governance Committee of the Board
of Directors
Dated: December 26, 2013 |
ROBERT F. DOMAN |
/s/ Robert F. Doman |
Dated: December 23, 2013 |